Tonix Pharmaceuticals Receives IND Clearance for TNX-201 in Episodic Tension-Type Headache

NEW YORK, Oct. 21, 2014 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (TNXP) announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to study TNX-201 for the treatment of episodic tension-type headache. Tonix will evaluate the safety, tolerability, and pharmacokinetics of TNX-201 in a healthy volunteers […]

The post Tonix Pharmaceuticals Receives IND Clearance for TNX-201 in Episodic Tension-Type Headache appeared first on Posts Headache.

UPDATE 2

Medscape-In its letter, the FDA revealed worry regarding the delivery tool for the aerosol migraine prescription, mentioning “content uniformity on the improved container loading procedure and on requirements for tool actuation,” Allergan stated. “We believe we may have … FDA give away its third being rejected for Allergan’s migraine medicine SempranaFierceBiotechAllergan states United States FDA delays Semprana choice, OKs OzurdexKDALAllergan succeeds US authorization for a therapy of vision loss in diabeticsIrish TimesOrange Region Business Journalall 32 news articles »& raquo;.

Tonix Pharmaceuticals to be Added to the MSCI Global Micro Cap Index

NEW YORK, May 28, 2014 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (TNXP), a clinical-stage pharmaceutical company, will be added to the Morgan Stanley Capital International (MSCI) Global Micro Cap Index, effective May 30, 2014. Tonix develops first-in-class medicines for common disorders of the central nervous system, including fibromyalgia (FM), post-traumatic stress disorder (PTSD) and episodic tension-type headache. “It is gratifying that Tonix’s progress in the last year has been recognized by MSCI through inclusion in its index, as well …

eNeura, Inc. Receives FDA Clearance for SpringTMS® Migraine Treatment Device

BALTIMORE, May 23, 2014 /PRNewswire/ — eNeura, Inc., a privately held medical technology company, announced today that it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its SpringTMS® migraine treatment device.  SpringTMS is the first medical device available to patients in the United States for the acute treatment of pain associated with migraine headache with aura. SpringTMS is a prescription-only device that utilizes single-pulse Transcranial Magnetic Stimulation (sTMS) to induce very mild electrical currents that can depolarize neurons …

9 highly effective migraine treatments

It says a lot about the desperation of migraine sufferers that researchers are studying how they describe their headaches on Twitter. (Perhaps not surprisingly, it turns out the words worst and massive are the most common adjectives used.) As the 36 million Americans who get these uberhead-aches know, it takes more than 140 characters to describe the true misery–and a host of strategies to keep the pain under control.  Most people who get migraines–defined as having at least two of …

Botox for migraines? Here are a few alternatives to consider

[unable to retrieve full-text content]Olesen is of the opinion that the FDA made a mistake in approving the botox treatment for migraine. According to him, half of the trial participants overused pain medications, preventing the researchers from telling whether the participants had chronic … Did you find this useful? More Info: JustNoHeadache.com Headache

IntelGenx and RedHill Biopharma Announce Commencement of a Bioavailability Study With Anti

SAINT LAURENT, Quebec, April 28, 2014 (GLOBE NEWSWIRE) — IntelGenx Corp. (IGX.V) (IGXT) (“IntelGenx”), a Canadian drug delivery company focused on oral drug delivery, together with RedHill Biopharma Ltd. (RDHL) (RDHL) (“RedHill”), an emerging Israeli biopharmaceutical company focused primarily on the development and acquisition of late clinical-stage proprietary drugs, today announced the commencement of a comparative bioavailability clinical study comparing their anti-migraine VersaFilm(TM) Product to the European reference drug. The study is intended to support the planned submission of a …

Electronic Headband Prevents Migraines With Tiny Jolts

By stimulating the nerve, which plays a role in many migraines, the device was shown to help prevent the headaches in a clinical test involving 67 people. Some got the Cefaly device and others used a sham headband. The people who wore the Cefaly device …FDA approves Belgium-made ‘headband’ device for use in fighting migraines …al.com […]

Got a headache? You’re not alone

Neurologist & Mind-Body Doc Shares Natural Migraine Prevention Tips Headaches are the number 3 reason women ages 18 to 44 go to emergency rooms, and the fifth-leading cause of emergency room visits among all Americans, according to a 2013 National Institutes of Health report, which calls headaches a major public health problem. Advertisement “The key […]

eNeura Files 510(k) with the FDA for SpringTMS® Migraine Treatment

SUNNYVALE, Calif. and BALTIMORE, Jan. 27, 2014 /PRNewswire/ – eNeura Inc., a privately held medical technology company, announced today that it filed a 510(k) with the U.S. Food and Drug Administration (FDA) for the SpringTMS® transcranial magnetic stimulation (TMS) device.  SpringTMS is a second-generation medical device based on eNeura’s ground-breaking CerenaTMS™, which recently received FDA clearance […]

  • DON’T  LEAVE  EMPTY-HANDED !!!

    Download your FREE Report on Headache

    slide12t

    Just a sneak peek…

    • Guide to cluster headache
    • Why do you get a headache?
    • Headache and migraine pain relief through hypnotherapy
    • Can stress cause severe headache?
    • Caffeine: the culprit behind our migraines
    • Menopause and headaches
    • Sinusitis: how serious is it?
    Download It Completely FREE

    Just Insert Your Name and email

    We will also send you a Complimentary copy of our Headache Newsletter. Our newsletter subscription has the latest information on Headache and Migraine treatments.

    We respect your privacy. We will NEVER sell, rent or share your email address. That’s more than a policy, it’s our personal guarantee!

  • Now you can have the Latest News on Headache

    hedac02-220

    Worried about Headache and Migraine? You can have now information about the latest treatments and medical research. All this and more in our Headache Newsletter.slide11t

    Try it for four weeks. We will even send you FREE our bonus health e-book with your trial subscription.

    All for just ONE PENNY

    Get the latest information – don’t be left in the dark on your condition.

     CLICK HERE 

    Check our special offer: Subscribe to one newsletter, get another newsletter for FREE!